Advertisement
UK markets closed
  • FTSE 100

    7,682.50
    +52.48 (+0.69%)
     
  • FTSE 250

    19,354.38
    +299.51 (+1.57%)
     
  • AIM

    741.31
    +4.81 (+0.65%)
     
  • GBP/EUR

    1.1668
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2655
    +0.0029 (+0.23%)
     
  • Bitcoin GBP

    48,963.75
    +63.67 (+0.13%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,137.08
    +40.81 (+0.80%)
     
  • DOW

    39,087.38
    +90.99 (+0.23%)
     
  • CRUDE OIL

    79.81
    +1.55 (+1.98%)
     
  • GOLD FUTURES

    2,091.60
    +36.90 (+1.80%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • HANG SENG

    16,589.44
    +78.00 (+0.47%)
     
  • DAX

    17,735.07
    +56.88 (+0.32%)
     
  • CAC 40

    7,934.17
    +6.74 (+0.09%)
     

United Kingdom Pharmaceutical (Generic Drugs v/s Branded Drugs) Markets, Competition, Forecast & Opportunities, 2027

Company Logo
Company Logo

Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Pharmaceutical Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering.

United Kingdom pharmaceutical market is expected to register robust growth in the forecast period, 2023-2027

Innovations in the fields of oncology, autoimmune, and diabetes treatment will continue to augment the United Kingdom pharmaceutical market.

Emerging markets will see a steady rise in people seeking treatment for these diseases owing to the advancements in treatments and prevention will continue to propel the market growth. A growing number of patients who experience chronic ailments or pain drives the market growth.

In addition to this, chronic illnesses including hypertension and mental health issues are the key driver of the growth in the pharmaceutical market in United Kingdom. The pharmaceuticals that treat rare diseases as advancements in pharmaceuticals offer numerous solutions and up-gradations in medicine uncover more problems.

The Expanding Geriatric Population is Projected to Fuel the Market Growth

Chronic conditions are on the rise and patients are often suffering from more than just one ailment. This development is intensified owing to the growing middle-class and escalating adoption of sedentary lifestyles in emerging markets, which results in obesity, diabetes, and other costly health conditions.

Chronic non-communicable disease prevalence such as cardiovascular diseases or cancer is accelerating the demand for pharmaceuticals. The increasing elderly population and the high requirement for more medical care especially for the older population are driving the growth of the pharmaceutical market.

Government health programs including Medicaid and Medicare enable a wider range of seniors to be covered. Additionally, advancements in healthcare that people are living longer and requiring services for a longer period.

Growing Number of Chronic Diseases is Expected to Bolster the Market Growth

The escalating demand for healthcare and innovative solutions is one of the primary factors propelling market growth. Digitalization, big data, and artificial intelligence drive the transformation of the pharmaceutical sector and allow companies to enhance drug development and patient care beyond the treatment of diseases, which provides a new revenue stream.

For patient care, digital solutions allow the shift from a disease focus to an integrated approach from prevention, screening, diagnostic, treatment, and aftercare. Continuous technological advancement and novel therapeutic approaches have the potential to not only treat but also assist in curing diseases - or identifying and eliminating risk factors before a disease develops.

Part of this development is personalized therapies, a promising approach tailoring medical treatment to the individual characteristics of each patient. The emerging associations between the human microbiome, health, and disease are leading to novel diagnostics and therapeutics thereby improving personalized medicine. All these aforementioned factors are expected to augment the pharmaceutical market across United Kingdom during the forecast years.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom Pharmaceutical market.

  • Takeda Pharmaceutical Company Limited

  • GlaxoSmithKline Plc.

  • Vertex Pharmaceuticals (U.K.) Limited

  • Pfizer Limited

  • Novartis UK Limited

  • AstraZeneca UK Limited

  • Bristol-Myers Squibb Pharmaceuticals Limited

  • Roche Products Limited

  • Sanofi UK

  • Sun Pharmaceuticals UK Limited

Report Scope:

United Kingdom Pharmaceutical Market, By Drug Type:

  • Generic Drugs

  • Branded Drugs

United Kingdom Pharmaceutical Market, By Product Type:

  • Prescription Drugs

  • Over-The-Counter Drugs

United Kingdom Pharmaceutical Market, By Application:

  • Cardiovascular

  • Musculoskeletal

  • Oncology

  • Anti-infective

  • Metabolic Disorder

  • Others

United Kingdom Pharmaceutical Market, By Distribution Channel:

  • Retail Pharmacy

  • Hospital Pharmacy

  • E-Pharmacy

United Kingdom Pharmaceutical Market, By Region:

  • London

  • Southeast

  • East Anglia

  • Scotland

  • Southwest

  • East Midlands

  • Yorkshire & Humberside

  • Rest of United Kingdom

For more information about this report visit https://www.researchandmarkets.com/r/b181vk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900